FY2025 EPS Estimates for Amedisys Boosted by William Blair

Amedisys, Inc. (NASDAQ:AMED - Free Report) - Stock analysts at William Blair boosted their FY2025 earnings per share estimates for shares of Amedisys in a research note issued to investors on Thursday, April 24th. William Blair analyst M. Larew now expects that the health services provider will post earnings per share of $4.74 for the year, up from their prior forecast of $4.45. The consensus estimate for Amedisys' current full-year earnings is $4.40 per share. William Blair also issued estimates for Amedisys' Q4 2025 earnings at $1.11 EPS.

Other equities research analysts have also issued research reports about the company. Stephens reiterated an "equal weight" rating and issued a $101.00 target price on shares of Amedisys in a research note on Tuesday, March 4th. Royal Bank of Canada restated an "outperform" rating and issued a $100.00 price target on shares of Amedisys in a report on Wednesday, April 16th. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $100.75.

Amedisys Stock Up 0.8 %

Amedisys stock traded up $0.72 during trading on Monday, reaching $95.92. 549,460 shares of the company's stock were exchanged, compared to its average volume of 409,698. The company's 50-day moving average is $92.49 and its two-hundred day moving average is $91.77. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. Amedisys has a 52-week low of $82.15 and a 52-week high of $98.95. The firm has a market cap of $3.15 billion, a price-to-earnings ratio of 38.06, a PEG ratio of 1.78 and a beta of 0.96.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share for the quarter, beating analysts' consensus estimates of $1.13 by $0.12. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The firm had revenue of $594.78 million for the quarter, compared to analysts' expectations of $597.43 million. During the same period in the previous year, the company posted $1.03 earnings per share. Amedisys's revenue was up 4.1% compared to the same quarter last year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the business. Hexagon Capital Partners LLC increased its holdings in Amedisys by 108.1% during the 1st quarter. Hexagon Capital Partners LLC now owns 310 shares of the health services provider's stock worth $29,000 after purchasing an additional 161 shares during the last quarter. MassMutual Private Wealth & Trust FSB grew its position in shares of Amedisys by 56.1% during the first quarter. MassMutual Private Wealth & Trust FSB now owns 334 shares of the health services provider's stock worth $31,000 after buying an additional 120 shares in the last quarter. Fifth Third Bancorp increased its stake in shares of Amedisys by 68.1% in the first quarter. Fifth Third Bancorp now owns 348 shares of the health services provider's stock worth $32,000 after buying an additional 141 shares during the last quarter. Blue Trust Inc. raised its holdings in Amedisys by 55.1% in the fourth quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock valued at $34,000 after acquiring an additional 124 shares in the last quarter. Finally, UMB Bank n.a. boosted its stake in Amedisys by 100.0% during the 1st quarter. UMB Bank n.a. now owns 386 shares of the health services provider's stock valued at $36,000 after acquiring an additional 193 shares during the last quarter. Institutional investors and hedge funds own 94.36% of the company's stock.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.